-
Something wrong with this record ?
Percutaneous absorption of N,N-dimethylformamide in humans
J Mraz, H Nohova
Language English Country Germany
Grant support
IZ265
MZ0
CEP Register
PubMed
1399027
DOI
10.1007/bf00381473
Knihovny.cz E-resources
- MeSH
- Acetylcysteine analogs & derivatives urine MeSH
- Dimethylformamide analogs & derivatives pharmacokinetics chemistry metabolism MeSH
- Adult MeSH
- Formamides metabolism MeSH
- Skin Absorption * MeSH
- Middle Aged MeSH
- Humans MeSH
- Gases MeSH
- Solvents pharmacokinetics chemistry metabolism MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
Skin penetration fo N,N-dimethylformamide (DMF) liquid or vapour was studied in volunteers. Exposure to liquid DMF was performed in two ways: in a "dipping experiment", one hand was dipped up to the wrist in DMF for 2-20 min, while in a "patch experiment", 2 mmol DMF was applied to the skin and allowed to be absorbed completely. The period of exposure to DMF vapour (50 mg.m-3) was 4 h. The DMF metabolites N-hydroxymethyl-N-methylformamide ("MF"), N-hydroxymethylformamide ("F"), and N-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC) were monitored in the urine. Liquid DMF was absorbed through the skin at a rate of 9.4 mg.cm-2.h-1. Percutaneous absorption of DMF vapour depended strongly on ambient temperature and humidity and accounted for 13%-36% of totally excreted "MF". The results suggest that skin absorption of liquid DMF is likely to contribute to occupational exposure substantially more than penetration of DMF vapour. The yield of metabolites after transdermal DMF absorption was only half of that seen after pulmonary absorption. Elimination of "MF" and "F" but not that of AMCC was delayed, which supports the contention that AMCC should be used instead of "MF" as the most suitable biomarker of DMF in cases where percutaneous intake can occur.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13039080
- 003
- CZ-PrNML
- 005
- 20140108083631.0
- 007
- ta
- 008
- 131213s1992 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/bf00381473 $2 doi
- 035 __
- $a (PubMed)1399027
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Mráz, Jaroslav, $d 1960- $7 xx0052801 $u Institute of Hygiene and Epidemiology, Prague, Czechoslovakia
- 245 10
- $a Percutaneous absorption of N,N-dimethylformamide in humans / $c J Mraz, H Nohova
- 504 __
- $a Literatura
- 520 9_
- $a Skin penetration fo N,N-dimethylformamide (DMF) liquid or vapour was studied in volunteers. Exposure to liquid DMF was performed in two ways: in a "dipping experiment", one hand was dipped up to the wrist in DMF for 2-20 min, while in a "patch experiment", 2 mmol DMF was applied to the skin and allowed to be absorbed completely. The period of exposure to DMF vapour (50 mg.m-3) was 4 h. The DMF metabolites N-hydroxymethyl-N-methylformamide ("MF"), N-hydroxymethylformamide ("F"), and N-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC) were monitored in the urine. Liquid DMF was absorbed through the skin at a rate of 9.4 mg.cm-2.h-1. Percutaneous absorption of DMF vapour depended strongly on ambient temperature and humidity and accounted for 13%-36% of totally excreted "MF". The results suggest that skin absorption of liquid DMF is likely to contribute to occupational exposure substantially more than penetration of DMF vapour. The yield of metabolites after transdermal DMF absorption was only half of that seen after pulmonary absorption. Elimination of "MF" and "F" but not that of AMCC was delayed, which supports the contention that AMCC should be used instead of "MF" as the most suitable biomarker of DMF in cases where percutaneous intake can occur.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a acetylcystein $x analogy a deriváty $x moč $7 D000111
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a dimethylformamid $x analogy a deriváty $x farmakokinetika $x chemie $x metabolismus $7 D004126
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a formamidy $x metabolismus $7 D005559
- 650 02
- $a plyny $7 D005740
- 650 02
- $a lidé $7 D006801
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a lidé středního věku $7 D008875
- 650 12
- $a kožní absorpce $7 D012869
- 650 02
- $a rozpouštědla $x farmakokinetika $x chemie $x metabolismus $7 D012997
- 700 1_
- $a Nohová, Hana $7 xx0097601
- 773 0_
- $t International archives of occupational and environmental health $x 0340-0131 $g Roč. 64, č. 2 (1992), s. 79-83 $p Int Arch Occup Environ Health $w MED00009876
- 773 0_
- $p Int Arch Occup Environ Health $g 64(2):79-83, 1992 $x 0340-0131
- 910 __
- $a ABA008 $b A 986 $y 4 $z 0
- 990 __
- $a 20131213100453 $b ABA008
- 991 __
- $a 20140108084331 $b ABA008
- 999 __
- $a ok $b bmc $g 1003566 $s 837580
- BAS __
- $a 3
- BMC __
- $a 1992 $b 64 $c 2 $d 79-83 $i 0340-0131 $m International archives of occupational and environmental health $x MED00009876 $n Int Arch Occup Environ Health
- GRA __
- $a IZ265 $p MZ0
- LZP __
- $a 2013-12/išbo